Skip to main content
ADVANCED MEDICAL SOLUTIONS GROUP PLC logo

ADVANCED MEDICAL SOLUTIONS GROUP PLC — Investor Relations & Filings

Ticker · AMS ISIN · GB0004536594 LEI · 213800HJP6OWOSZI1L74 IL Manufacturing
Open in API
Filings indexed 488 across all filing types
Latest filing 2025-05-14 AGM Information
Country GB United Kingdom
Listing IL AMS

About ADVANCED MEDICAL SOLUTIONS GROUP PLC

https://admedsol.com/

Advanced Medical Solutions Group plc is a world-leading independent developer and manufacturer of innovative tissue-healing technologies. The company operates through two primary divisions: Surgical and Woundcare. The Surgical portfolio includes a range of products such as tissue adhesives, sutures, haemostats, and internal fixation devices designed for tissue closure and sealing. The Woundcare division focuses on advanced products for managing acute and chronic wounds, utilizing high-performance natural and synthetic polymers. The company is dedicated to delivering high-quality, innovative solutions that improve patient outcomes and provide value to clinicians and healthcare payors.

Recent filings

Filing Released Lang Actions
Timing of AGM and Change of Dividend Record Date
AGM Information Classification · 98% confidence The document is an RNS announcement from Advanced Medical Solutions Group plc regarding the rescheduling of their Annual General Meeting (AGM) and a subsequent change to the record date for a final dividend. While it mentions an AGM and a dividend, it is an announcement of administrative changes rather than the AGM materials themselves or the dividend declaration itself. Given the nature of the announcement as a regulatory update regarding corporate scheduling, it fits best under the RNS category.
2025-05-14 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of a grant of share options (LTIPs) to company directors (CEO and CFO). It explicitly follows the EU Market Abuse Regulation disclosure requirements for transactions by persons discharging managerial responsibilities (PDMRs). This falls directly under the category of Director's Dealing, which covers insider transactions and share-based compensation grants to executives.
2025-05-06 English
Total Voting Rights
Regulatory Filings Classification · 100% confidence The document is a 'Total Voting Rights' announcement issued by Advanced Medical Solutions Group plc in accordance with the FCA's Disclosure and Transparency Rule 5.6.1. This type of regulatory disclosure, which provides the denominator for shareholders to calculate their interest, does not fit into specific categories like M&A, dividends, or financial reports. Therefore, it is classified as a general Regulatory Filing (RNS).
2025-04-30 English
Response to Rule 2.8 Announcement
Regulatory Filings Classification · 98% confidence The document is an official regulatory announcement (RNS) regarding a 'Rule 2.8' statement under the City Code on Takeovers and Mergers. It confirms that Montagu Private Equity LLP does not intend to make an offer for Advanced Medical Solutions Group plc. Since this relates to M&A activity (specifically the cessation of a potential takeover bid), it falls under the M&A Activity category.
2025-04-24 English
Form 8.3 - Advanced Medical Solutions Group PLC
Director's Dealing Classification · 95% confidence The document is explicitly titled 'FORM 8.3 - Advanced Medical Solutions Group PLC' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure or Dealing Disclosure made by a person holding 1% or more interest in relevant securities during a takeover situation. This type of filing relates to insider transactions and ownership changes during a takeover bid, which falls under the scope of director/insider dealings, but is specifically mandated by takeover regulations (Rule 8.3). Among the provided codes, 'DIRS' (Director's Dealing) is the closest fit for reporting personal share transactions by executives/insiders, even though this specific form (Form 8.3) is unique to takeover disclosures. Since there is no specific code for 'Takeover Disclosure Form 8.3', and it details dealings in relevant securities by a person with interests, DIRS is the most appropriate classification, as it covers insider transactions. The document is not a general regulatory announcement (RNS) because it is a highly specific disclosure type.
2025-04-23 English
Rule 2.9 Announcement
M&A Activity Classification · 95% confidence The document is a 'Rule 2.9 Announcement' issued by Advanced Medical Solutions Group plc. This is a standard regulatory disclosure required under the UK City Code on Takeovers and Mergers to confirm the total number of voting rights and share capital in issue during an offer period. While it relates to M&A activity (Takeover Code), it is specifically a regulatory disclosure of share capital rather than a merger proposal or takeover bid document itself. Given the nature of RNS (Regulatory News Service) filings that do not fit into specific categories like M&A or Share Issues, it is best classified as a general Regulatory Filing (RNS).
2025-04-17 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.